Explore stories from Atlantic Canada.
Tentative trial dates set for four teens charged with murder | SaltWire #newsupdate #halifax #courtLONDON - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it would buy a controlling stake of about 60% in Single Use Support, an Austria-based life science tools company.
Novo Holdings CEO Kasim Kutay told Reuters in October that the huge Wegovy windfall would increase the size of deals it would do in healthcare, particularly for well-established life-science companies.Novo Holdings said the acquisition was part of its focus on companies that provide services to the pharmaceuticals industry.
Single Use Support, founded in 2017, makes equipment and consumables to support the production of drugs, in particular biologic medicines, cell and gene therapies, and mRNA vaccines.Single Use Support"got a huge boost" from business from Moderna during the COVID-19 pandemic, Johan Hueffer, senior partner in principal investments at Novo Holdings told Reuters.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk owner buys majority stake in Austrian life science tools companyExplore stories from Atlantic Canada.
Read more »
Novo Nordisk owner to invest $200 million in quantum computing startupsExplore stories from Atlantic Canada.
Read more »
No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk saysExplore stories from Atlantic Canada.
Read more »
Wegovy weight loss sustained for four years in trial, Novo Nordisk saysPatients taking Novo Nordisk's popular Wegovy obesity treatment maintained an average of 10 per cent weight loss after four years on the treatment, the company said on Tuesday.
Read more »
Wegovy weight loss sustained for four years in trial, Novo Nordisk saysExplore stories from Atlantic Canada.
Read more »
Wegovy weight loss sustained for four years in trial, Novo Nordisk saysExplore stories from Atlantic Canada.
Read more »